WBDE(SZ:002082) Sou Hu Cai Jing·2025-05-12 08:38Core Points - Wanbangde's stock closed at 5.72 yuan on May 12, down 1.04%, with a rolling PE ratio of 83.70 times and a total market value of 3.499 billion yuan [1] - The average PE ratio for the chemical pharmaceutical industry is 45.46 times, with a median of 26.94 times, placing Wanbangde at the 127th position in the industry ranking [1] - On May 12, the net inflow of main funds into Wanbangde was 934,100 yuan, showing an overall inflow trend over the past five days, totaling 245,800 yuan [1] Company Overview - Wanbangde Pharmaceutical Holdings Co., Ltd. specializes in the research, development, production, and sales of modern traditional Chinese medicine, chemical raw materials, and chemical preparations, as well as providing high-end medical device research, medical equipment services, and hospital engineering services [1] - The main products include cardiovascular system products, neurological system products, respiratory system products, digestive system products, psychiatric system products, orthopedic implants, medical devices, hospital engineering services, disposable sterile medical polymer consumables, and protective equipment [1] Financial Performance - In the first quarter of 2025, the company reported operating revenue of 315 million yuan, a year-on-year decrease of 26.58%, and a net profit of 15.2018 million yuan, a year-on-year decrease of 47.29%, with a sales gross margin of 33.85% [1]